# 60 DEGREES PHARMACEUTICALS I (SXTPW)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/SXTPW/

- Reporting holders: 5
- Reported value: $12.2K
- Shares held by institutions: 405,158 of 3,516,988 outstanding
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Walleye Capital LLC](https://holderbook.com/funds/1758720-walleye-capital-llc/) | $6.1K | 200,481 | 0.0% | 12 |
| [Clear Street Group Inc.](https://holderbook.com/funds/1881567-clear-street-group-inc/) | $4.4K | 145,969 | 0.0% | 4 |
| [TORNO CAPITAL, LLC](https://holderbook.com/funds/1974312-torno-capital-llc/) | $1.4K | 47,169 | 0.0% | 11 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](https://holderbook.com/funds/1446194-susquehanna-international-group-llp/) | $329 | 10,892 | 0.0% | 4 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $20 | 647 | 0.0% | 5 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 5 | $12.2K |
| Q1 2026 | 8 | $26.8K |
| Q4 2025 | 8 | $33.9K |
| Q3 2025 | 7 | $19.1K |
| Q2 2025 | 5 | $27.0K |
| Q1 2025 | 6 | $11.0K |
| Q4 2024 | 7 | $20.5K |
| Q3 2024 | 8 | $46.6K |
| Q2 2024 | 8 | $59.6K |
| Q1 2024 | 8 | $62.0K |
| Q4 2023 | 9 | $36.7K |
| Q3 2023 | 8 | $261.0K |